Literature DB >> 28183077

Restructuring Hedonic Dysregulation in Chronic Pain and Prescription Opioid Misuse: Effects of Mindfulness-Oriented Recovery Enhancement on Responsiveness to Drug Cues and Natural Rewards.

Eric L Garland1, Matthew O Howard, Jon-Kar Zubieta, Brett Froeliger.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28183077      PMCID: PMC5331925          DOI: 10.1159/000453400

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN: 0033-3190            Impact factor:   17.659


× No keyword cloud information.
  10 in total

Review 1.  Drug addiction, dysregulation of reward, and allostasis.

Authors:  G F Koob; M Le Moal
Journal:  Neuropsychopharmacology       Date:  2001-02       Impact factor: 7.853

2.  Brain potentials in affective picture processing: covariation with autonomic arousal and affective report.

Authors:  B N Cuthbert; H T Schupp; M M Bradley; N Birbaumer; P J Lang
Journal:  Biol Psychol       Date:  2000-03       Impact factor: 3.251

3.  Electrophysiological evidence that drug cues have greater salience than other affective stimuli in opiate addiction.

Authors:  D I Lubman; N B Allen; L A Peters; J F W Deakin
Journal:  J Psychopharmacol       Date:  2008-01-21       Impact factor: 4.153

4.  Responsiveness to drug cues and natural rewards in opiate addiction: associations with later heroin use.

Authors:  Dan I Lubman; Murat Yücel; Jonathan W L Kettle; Antonietta Scaffidi; Trudi Mackenzie; Julian G Simmons; Nicholas B Allen
Journal:  Arch Gen Psychiatry       Date:  2009-02

Review 5.  Claude Bernard and the heart-brain connection: further elaboration of a model of neurovisceral integration.

Authors:  Julian F Thayer; Richard D Lane
Journal:  Neurosci Biobehav Rev       Date:  2008-08-13       Impact factor: 8.989

6.  Allostatic dysregulation of natural reward processing in prescription opioid misuse: autonomic and attentional evidence.

Authors:  Eric L Garland; Brett Froeliger; Matthew O Howard
Journal:  Biol Psychol       Date:  2015-01-17       Impact factor: 3.251

7.  Development and validation of the Current Opioid Misuse Measure.

Authors:  Stephen F Butler; Simon H Budman; Kathrine C Fernandez; Brian Houle; Christine Benoit; Nathaniel Katz; Robert N Jamison
Journal:  Pain       Date:  2007-05-09       Impact factor: 6.961

Review 8.  The downward spiral of chronic pain, prescription opioid misuse, and addiction: cognitive, affective, and neuropsychopharmacologic pathways.

Authors:  Eric L Garland; Brett Froeliger; Fadel Zeidan; Kaitlyn Partin; Matthew O Howard
Journal:  Neurosci Biobehav Rev       Date:  2013-08-26       Impact factor: 8.989

9.  Mindfulness-oriented recovery enhancement for chronic pain and prescription opioid misuse: results from an early-stage randomized controlled trial.

Authors:  Eric L Garland; Eron G Manusov; Brett Froeliger; Amber Kelly; Jaclyn M Williams; Matthew O Howard
Journal:  J Consult Clin Psychol       Date:  2014-02-03

Review 10.  Restructuring reward processing with Mindfulness-Oriented Recovery Enhancement: novel therapeutic mechanisms to remediate hedonic dysregulation in addiction, stress, and pain.

Authors:  Eric L Garland
Journal:  Ann N Y Acad Sci       Date:  2016-04-01       Impact factor: 5.691

  10 in total
  18 in total

Review 1.  Positive psychological states in the arc from mindfulness to self-transcendence: extensions of the Mindfulness-to-Meaning Theory and applications to addiction and chronic pain treatment.

Authors:  Eric L Garland; Barbara L Fredrickson
Journal:  Curr Opin Psychol       Date:  2019-01-14

Review 2.  A dual process perspective on advances in cognitive science and alcohol use disorder.

Authors:  Kristen P Lindgren; Christian S Hendershot; Jason J Ramirez; Edward Bernat; Mauricio Rangel-Gomez; Kirsten P Peterson; James G Murphy
Journal:  Clin Psychol Rev       Date:  2018-04-11

3.  Behavioral preference for viewing drug v. pleasant images predicts current and future opioid misuse among chronic pain patients.

Authors:  Scott J Moeller; Adam W Hanley; Eric L Garland
Journal:  Psychol Med       Date:  2019-04-15       Impact factor: 7.723

Review 4.  Mindfulness-based interventions for substance use disorders.

Authors:  Simon B Goldberg; Brian Pace; Matas Griskaitis; Reinhard Willutzki; Nicole Skoetz; Sven Thoenes; Aleksandra E Zgierska; Susanne Rösner
Journal:  Cochrane Database Syst Rev       Date:  2021-10-20

Review 5.  Emotion regulation as a transdiagnostic factor underlying co-occurring chronic pain and problematic opioid use.

Authors:  Rachel V Aaron; Patrick H Finan; Stephen T Wegener; Francis J Keefe; Mark A Lumley
Journal:  Am Psychol       Date:  2020-09

6.  Mindfulness-oriented recovery enhancement reduces opioid dose in primary care by strengthening autonomic regulation during meditation.

Authors:  Eric L Garland; Justin Hudak; Adam W Hanley; Yoshio Nakamura
Journal:  Am Psychol       Date:  2020-09

7.  Effects of Mindfulness-Oriented Recovery Enhancement Versus Social Support on Negative Affective Interference During Inhibitory Control Among Opioid-Treated Chronic Pain Patients: A Pilot Mechanistic Study.

Authors:  Eric L Garland; Myranda A Bryan; Sarah E Priddy; Michael R Riquino; Brett Froeliger; Matthew O Howard
Journal:  Ann Behav Med       Date:  2019-08-29

8.  Restructuring Reward Mechanisms in Nicotine Addiction: A Pilot fMRI Study of Mindfulness-Oriented Recovery Enhancement for Cigarette Smokers.

Authors:  B Froeliger; A R Mathew; P A McConnell; C Eichberg; M E Saladin; M J Carpenter; E L Garland
Journal:  Evid Based Complement Alternat Med       Date:  2017-03-08       Impact factor: 2.629

9.  A pilot randomized clinical trial of mindfulness-oriented recovery enhancement as an adjunct to methadone treatment for people with opioid use disorder and chronic pain: Impact on illicit drug use, health, and well-being.

Authors:  Nina A Cooperman; Adam W Hanley; Anna Kline; Eric L Garland
Journal:  J Subst Abuse Treat       Date:  2021-05-08

Review 10.  Emotion dysregulation as a transdiagnostic mechanism of opioid misuse and suicidality among chronic pain patients.

Authors:  Michael R Riquino; Sarah E Priddy; Matthew O Howard; Eric L Garland
Journal:  Borderline Personal Disord Emot Dysregul       Date:  2018-06-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.